Achieve Life Sciences, Inc.

NASDAQ:ACHV

Biotechnology

Healthcare
$6.78 -7.00%

-$0.38 today

Market cap
$697.68M
Beta
2.26
P/E (TTM)
-5.1
EPS (TTM)
-$0.97
52W Low $2.00High $6.16

Volume 1.09M

Average 1.44M

Returns on capital

Achieve Life Sciences, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-254.0%

avg 44.6%

ROIC

-150.5%

avg -101.8%

ROA

-130.8%

avg -89.9%

Analysis

ROA is currently the strongest return metric at -130.8% versus its period average of -89.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Erik Atkisson

Chief Legal OfficerUSD 521.02K54250.00K0.24%

Benjamin Halladay

Chief Financial OfficerUSD 425.24K400<0.01%

Mark K. Oki

Chief Financial OfficerUSD 425.24K57180.00K0.18%

Andrew D. Goldberg

CEO, President & Director—440<0.01%

Mark L. Rubinstein

Chief Medical Officer—58——

Gloria Cosgrove

Senior Vice President of Global Quality————

Kaitlyn Tuson

Senior Vice President of Marketing & Communications————

Ronald Dadino

Senior Vice President of Chemistry, Manufacturing & Controls and Supply Chain————

Jerry Wan

Vice President of Finance & Principal Accounting Officer—4470.30K0.07%

Mark Zappia

Senior Vice President of Commercial————

Nicole Jones

Vice President of Strategic Communications & Stakeholder Relations————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 5, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

1

$175,176.62

Net Transaction Value

−$175,176.62

Net selling

Most Active

Stewart Richard Alistair

1 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 19, 26

Stewart Richard Alistair

Direct

Sell$175.2K

Summary

Insiders reported 0 buys worth $0.00 and 1 sells worth $175,176.62 over the last 12 months. That adds up to net selling of $175,176.62. Stewart Richard Alistair was the most active insider with 1 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A5 analysts
RevenueN/AN/AN/A
N/A6 analysts
Net IncomeN/AN/AN/A
N/A6 analysts
EBITN/AN/AN/A
N/A6 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Achieve Life Sciences, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Questions

Management questions

Common questions about ACHV's management, answered from reported figures.

Who manages ACHV?

Achieve Life Sciences, Inc. (ACHV) lists 11 active executives. The top listed executive is Andrew D. Goldberg, CEO, President & Director.

Are ACHV insiders buying or selling?

Recent insider activity shows net buying of $30.49M.